Northwest Biotherapeutics, Inc.
NWBO
$0.17
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.73M | -43.89M | -60.16M | -89.77M | -82.32M |
| Total Depreciation and Amortization | 3.02M | 2.69M | 2.34M | 2.04M | 2.04M |
| Total Amortization of Deferred Charges | 1.43M | 1.83M | 1.89M | 2.13M | 2.27M |
| Total Other Non-Cash Items | -19.92M | -13.17M | -1.79M | 19.44M | 16.35M |
| Change in Net Operating Assets | 4.87M | 4.69M | 12.96M | 15.99M | 17.14M |
| Cash from Operations | -48.34M | -47.85M | -44.76M | -50.18M | -44.52M |
| Capital Expenditure | -1.43M | -1.54M | -1.50M | -677.00K | -651.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -311.00K | -311.00K | -311.00K | -311.00K | -- |
| Cash from Investing | -1.75M | -1.85M | -1.82M | -988.00K | -651.00K |
| Total Debt Issued | 34.14M | 31.52M | 31.26M | 31.78M | 29.62M |
| Total Debt Repaid | -2.32M | -1.16M | -1.27M | -1.65M | -1.98M |
| Issuance of Common Stock | 9.90M | 17.11M | 19.34M | 21.55M | 23.83M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 267.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.00K | -666.00K | -- | 0.00 | 0.00 |
| Cash from Financing | 41.73M | 46.80M | 49.33M | 51.68M | 51.74M |
| Foreign Exchange rate Adjustments | 4.63M | 1.91M | -1.88M | 1.11M | -5.14M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.72M | -993.00K | 865.00K | 1.62M | 1.44M |